Duo Oncology
Latest round
- Seed
Last raised
- Aug 2023
Total raised
- $4.3M
Investors
- 6
About Duo Oncology
Based in Pennsylvania, US, and founded in 2020, Duo Oncology Inc. provides cancer treatment therapies using nanotechnology. The company was co-founded by Sam Rothstein, who is leading the firm as CEO as of 2023., Innovation Works, LifeX Ventures, NuFund Venture Group, and Ulu Ventures. The business offers Duo’s nanomedicine platform for treating tumors that have already spread. With a novel kind of monotherapy, the company's approach transforms outcomes for patients with pancreatic cancer, bile duct cancer, and recurrent metastatic illness.
Who invested in Duo Oncology
6 investors across 2 rounds
See all investors in Duo Oncology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Duo Oncology
Who invested in Duo Oncology?
Duo Oncology has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Duo Oncology raised?
Duo Oncology has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Duo Oncology last raise money?
Duo Oncology's most recent round on record is a Seed, in Aug 2023.
What does Duo Oncology do?
Based in Pennsylvania, US, and founded in 2020, Duo Oncology Inc.
Where is Duo Oncology headquartered?
Duo Oncology is headquartered in Pittsburgh, US.
Which VCs invest in companies like Duo Oncology?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Duo Oncology's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Seed
Raising like Duo Oncology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.